Filter News

News By Country

None Found

News By Tag

April 2025
Sa	Fr	Th	We	Tu	Mo	Su
19	18	17	16	15	14	13

Public Company News

Business Press Releases

Ophthalmic Press Releases

Topics Locations Industries Dates

IVIEW Therapeutics Inc. Announces Dosing of First Patient in Phase 1/2 Clinical Trial of IVW-1001 for Dry Eye Disease

By IVIEW Therapeutics Inc.

IVIEW Therapeutics Inc., a clinical stage biotechnology company advancing innovative treatments for ocular diseases, proudly announces the dosing of the first patient in the Phase 1/2 clinical trial of IVW-1001 Ophthalmic Eyelid Wipe.

Page updated every 10 minutes

Most Viewed

Nevada Supreme Court Faces Pivotal Decision in Probate Appeal Involving Alleged Judicial Misconduct and Fiduciary Fraud - 2274 views

Rischad Whitfield, "The Footwork King," Denounces Crimes of Former Trainer Delfonte Diamond - 1479 views

Jayson Warner Smith joins the cast of Tulsa King, The Good Daughter and Murdaugh Murders in 2025 - 1315 views

USDi Partners Notes Launch of the USDi Coin, the First US Currency to Permanently Preserve Purchasing Power - 1046 views

Revolutionary Partnership Bridging AI/Youth Sports/Business - 1029 views

Top Daily News

FeelWise to Exhibit at ATD 2025 International Conference & EXPO in Washington, DC - 484 views

New Devotional - Made in the Middle - Helps Readers Find Strength and Purpose in Life's Waiting Seasons - 467 views

Webinar Announcement: Mexico's Evolving AML/CFT Environment: FATF Review and FTO Designations - 371 views

Grammy Winner Cory Henry To Host Easter Sunday Celebration Concert In Inglewood - 291 views

Kuna Dad And Former Mlb Player Brandon Barnes Team Up To Build $120 Million Youth Sports Complex - 196 views